Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway.

Joddar B, Reen RK, Firstenberg MS, Varadharaj S, McCord JM, Zweier JL, Gooch KJ.

Free Radic Biol Med. 2011 Mar 15;50(6):700-9. doi: 10.1016/j.freeradbiomed.2010.12.008. Epub 2010 Dec 15.

PMID:
21167278
2.

Arterial levels of oxygen stimulate intimal hyperplasia in human saphenous veins via a ROS-dependent mechanism.

Joddar B, Firstenberg MS, Reen RK, Varadharaj S, Khan M, Childers RC, Zweier JL, Gooch KJ.

PLoS One. 2015 Mar 23;10(3):e0120301. doi: 10.1371/journal.pone.0120301. eCollection 2015.

3.

Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.

Osgood MJ, Hocking KM, Voskresensky IV, Li FD, Komalavilas P, Cheung-Flynn J, Brophy CM.

J Vasc Surg. 2014 Jul;60(1):202-11. doi: 10.1016/j.jvs.2013.06.004. Epub 2013 Jul 30.

4.

Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.

Déglise S, Martin D, Probst H, Saucy F, Hayoz D, Waeber G, Nicod P, Ris HB, Corpataux JM, Haefliger JA.

J Vasc Surg. 2005 Jun;41(6):1043-52.

5.

Arterial pO₂ stimulates intimal hyperplasia and serum stimulates inward eutrophic remodeling in porcine saphenous veins cultured ex vivo.

Joddar B, Shaffer RJ, Reen RK, Gooch KJ.

Biomech Model Mechanobiol. 2011 Apr;10(2):161-75. doi: 10.1007/s10237-010-0224-8. Epub 2010 May 30.

PMID:
20512609
6.

Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.

Semsroth S, Stigler RG, Bernecker OY, Ruttmann-Ulmer E, Troppmair J, Macfelda K, Bonatti JO, Laufer G.

Eur J Cardiothorac Surg. 2009 Mar;35(3):515-20. doi: 10.1016/j.ejcts.2008.11.035. Epub 2009 Jan 23.

PMID:
19167904
7.

Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.

Hata JA, Petrofski JA, Schroder JN, Williams ML, Timberlake SH, Pippen A, Corwin MT, Solan AK, Jakoi A, Gehrig TR, Kontos CD, Milano CA.

J Thorac Cardiovasc Surg. 2005 Jun;129(6):1405-13.

8.

Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.

Petrofski JA, Hata JA, Gehrig TR, Hanish SI, Williams ML, Thompson RB, Parsa CJ, Koch WJ, Milano CA.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):27-33.

9.

Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia.

Tessier DJ, Komalavilas P, Liu B, Kent CK, Thresher JS, Dreiza CM, Panitch A, Joshi L, Furnish E, Stone W, Fowl R, Brophy CM.

J Vasc Surg. 2004 Jul;40(1):106-14.

10.

Vein quality influences neointimal hyperplasia in an organ culture model of human saphenous vein.

Wilson YG, Davies AH, Southgate K, Currie IC, Sheffield E, Baird RN, Lamont PM, Angelini GD.

Eur J Vasc Endovasc Surg. 1997 Jun;13(6):557-62.

PMID:
9236708
11.

Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.

Schachner T, Steger C, Heiss S, Bonaros N, Sterlacci W, Laufer G, Bonatti J.

Eur J Cardiothorac Surg. 2007 Dec;32(6):906-11. Epub 2007 Oct 17.

PMID:
17923411
12.

Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.

Schepers A, Eefting D, Bonta PI, Grimbergen JM, de Vries MR, van Weel V, de Vries CJ, Egashira K, van Bockel JH, Quax PH.

Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2063-9. Epub 2006 Jul 6.

13.

Influence of angioscopic vein graft preparation on development of neointimal hyperplasia in an organ culture model of human saphenous vein.

Wilson YG, Davies AH, Southgate K, Currie IC, Knight D, Patton D, Baird RN, Lamont PM, Angelini GD.

J Endovasc Surg. 1996 Nov;3(4):436-44.

PMID:
8959504
14.

The use of external mesh reinforcement to reduce intimal hyperplasia and preserve the structure of human saphenous veins.

Longchamp A, Alonso F, Dubuis C, Allagnat F, Berard X, Meda P, Saucy F, Corpataux JM, Déglise S, Haefliger JA.

Biomaterials. 2014 Mar;35(9):2588-99. doi: 10.1016/j.biomaterials.2013.12.041. Epub 2014 Jan 13.

PMID:
24429385
15.

Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery.

Huang B, Dreyer T, Heidt M, Yu JC, Philipp M, Hehrlein FW, Katz N, Al-Fakhri N.

Eur J Cardiothorac Surg. 2002 Jun;21(6):1002-8.

PMID:
12048077
16.

Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: tissue culture versus ex vivo continuous perfusion of human saphenous vein.

Rey J, Probst H, Mazzolai L, Bosman FT, Pusztaszeri M, Stergiopulos N, Ris HB, Hayoz D, Saucy F, Corpataux JM.

J Surg Res. 2004 Sep;121(1):42-9.

PMID:
15313374
17.

Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model.

Liu J, Gu X, Robbins D, Li G, Shi R, McCord JM, Zhao Y.

PLoS One. 2009;4(4):e5284. doi: 10.1371/journal.pone.0005284. Epub 2009 Apr 22.

18.

A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.

Petrofski JA, Hata JA, Williams ML, Parsa CJ, Thompson RB, Hanish SI, Gehrig TR, Koch WJ, Milano CA.

J Thorac Cardiovasc Surg. 2005 Dec;130(6):1683-90.

19.

Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo.

Muto A, Panitch A, Kim N, Park K, Komalavilas P, Brophy CM, Dardik A.

Vascul Pharmacol. 2012 Jan-Feb;56(1-2):47-55. doi: 10.1016/j.vph.2011.07.008. Epub 2011 Oct 17.

20.

Validation of an in vitro model of human saphenous vein hyperplasia.

Castronuovo JJ Jr, Smith TJ, Price RM.

J Vasc Surg. 2002 Jan;35(1):152-7.

Supplemental Content

Support Center